Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
18 hedge funds and large institutions have $9.5M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.31% less ownership
Funds ownership: 3.86% → 1.56% (-2.3%)
55% less capital invested
Capital invested by funds: $21.1M → $9.5M (-$11.6M)
Holders
18
Holding in Top 10
–
Calls
$11.5M
Puts
$2.01M
Top Buyers
| 1 | +$1.7M | |
| 2 | +$1.61M | |
| 3 | +$799K | |
| 4 |
Goldman Sachs
New York
|
+$463K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$399K |
Top Sellers
| 1 | -$7.1M | |
| 2 | -$2.85M | |
| 3 | -$2.3M | |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
-$1.04M |
| 5 |
HF
HRT Financial
New York
|
-$444K |